Pharma-Bio Serv (PBSV) Income towards Parent Company (2010 - 2026)
Pharma-Bio Serv (PBSV) posted Income towards Parent Company of $232986.0 for Q2 2026, up 609.03% on a QoQ basis from $32860.0 in Q1 2026, and up 144.34% year-over-year from $95353.0 in Q2 2025.
Pharma-Bio Serv (PBSV) Income towards Parent Company (2010 - 2026) Analysis & Trends
Pharma-Bio Serv's Income towards Parent Company history runs 17 years deep, the most recent figure standing at $232986.0 for Q2 2026.
- Quarterly Income towards Parent Company rose 144.34% year-over-year to $232986.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $51936.0 (up 127.45% YoY) and the FY2025 annual result came in at -$100463.0, up 87.08% from the prior year.
- Income towards Parent Company was $232986.0 for Q2 2026 at Pharma-Bio Serv, up from $32860.0 in the prior quarter.
- Across five years, Income towards Parent Company topped out at $526242.0 in Q3 2023 and bottomed at -$309194.0 in Q3 2024.
- A 5-year average of $94170.6 and a median of $64106.5 in 2025 frame the typical range for Income towards Parent Company.
- Annual changes were most pronounced in 2024 — Income towards Parent Company slumped 163.48% — and 2026, when it jumped 284.96%.
- Pharma-Bio Serv's Income towards Parent Company stood at $173379.0 in 2022, then plunged by 127.19% to -$47148.0 in 2023, then soared by 134.17% to $16111.0 in 2024, then sank by 100.63% to -$102.0 in 2025, then jumped by 228517.65% to $232986.0 in 2026.
- Business Quant data shows PBSV's Income towards Parent Company at $232986.0 in Q2 2026, $32860.0 in Q1 2026, and -$102.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 31.81 Bn | 24.49 Bn | 662.02 Mn |
| 2 | BrightSpring Health Services | 14.76 Bn | 13.86 Bn | 482.22 Mn |
| 3 | Healthequity | 8.36 Bn | 8.10 Bn | 256.31 Mn |
| 4 | Hinge Health | 5.91 Bn | 5.60 Bn | 154.23 Mn |
| 5 | 10x Genomics | 5.89 Bn | 5.35 Bn | 106.18 Mn |
| 6 | MiniMed | 4.45 Bn | 4.16 Bn | 480.00 Mn |
| 7 | Waystar Holding | 4.41 Bn | 4.35 Bn | 216.84 Mn |
| 8 | Doximity | 3.93 Bn | 3.18 Bn | 125.97 Mn |
| 9 | Privia Health | 3.10 Bn | 2.68 Bn | - |
| 10 | Pharma-Bio Serv | 13.28 Mn | 4.81 Mn | 902,041.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 232,986.00 |
| Jan 31, 2026 | 32,860.00 |
| Oct 31, 2025 | -102.00 |
| Jul 31, 2025 | -213,808.00 |
| Apr 30, 2025 | 95,353.00 |
| Jan 31, 2025 | 8,536.00 |
| Oct 31, 2024 | 16,111.00 |
| Jul 31, 2024 | -309,194.00 |
| Apr 30, 2024 | -213,817.00 |
| Jan 31, 2024 | -270,719.00 |
| Oct 31, 2023 | -47,148.00 |
| Jul 31, 2023 | 526,242.00 |
| Apr 30, 2023 | 404,654.00 |
| Jan 31, 2023 | 426,432.00 |
| Oct 31, 2022 | 173,379.00 |
| Jul 31, 2022 | 288,034.00 |
| Apr 30, 2022 | 240,027.00 |
| Jan 31, 2022 | 305,244.00 |
| Oct 31, 2021 | -4.87 Mn |
| Jul 31, 2021 | 2.28 Mn |